Exane Derivatives’s Boeing BA Stock Holding History
Bought
Maintained
Sold
Other funds holding BA
Exane Derivatives's BA Position: Q2 2022 in Review
Exane Derivatives sold out of Boeing (BA) in Q2 2022, closing a stake of 657 shares — an estimated $126K sold.
Exane Derivatives first reported a position in BA in Q4 2014 and held it in 20 quarters. The position peaked at $6.44M in Q4 2018. 1,901 funds tracked by Wall St. Rank hold BA as of Q2 2022.
- Exane Derivatives reported no remaining Boeing position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 657 Boeing shares in Q2 2022, an estimated $126K.
- Exane Derivatives first reported a position in Boeing in Q4 2014 and held it in 20 quarters.
- Exane Derivatives's Boeing position peaked at $6.44M in Q4 2018.
- 1,901 funds tracked by Wall St. Rank held Boeing as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.